WallStSmart
CGTX

Cognition Therapeutics Inc

NASDAQ: CGTX · HEALTHCARE · BIOTECHNOLOGY

$1.26
+6.78% today

Updated 2026-04-30

Market cap
$114.37M
P/E ratio
P/S ratio
EPS (TTM)
$-0.32
Dividend yield
52W range
$0 – $4
Volume
1.2M

Cognition Therapeutics Inc (CGTX) Earnings

Quarterly earnings history, analyst estimates, and stock price reaction.

EPS beat streak
6 of 8
Last 8 quarters
Avg EPS surprise
+53.5%
Last 4 quarters
Revenue YoY growth
Most recent quarter
EPS YoY growth
+100.0%
Most recent quarter

Earnings surprise history (last 12 quarters)

Beat estimate Missed estimate

Quarterly EPS and revenue trend

Quarterly revenue EPS (diluted)

How the stock reacts to earnings

Avg 1-day reaction
-7.2%
Last 3 reports
Positive reaction rate
33%
1 of 3 quarters
Largest single-day move
-34.2%
2026-03-26
Report dateEPS actualSurpriseClose beforeClose after1-day reaction
2026-04-01$0.00+100.0%$0.76$0.87+14.3%
2026-03-26$-0.02+74.2%$1.11$0.73-34.2%
2025-11-06$-0.06+40.0%$1.69$1.66-1.8%

Quarterly earnings history

Fiscal quarter endingEPS estimateEPS actualSurpriseRevenueYoY revenue
2026-03-31$-0.09$0.00+100.0%
2025-12-31$-0.08$-0.02+74.2%
2025-09-30$-0.10$-0.06+40.0%
2025-06-30$-0.11$-0.11+0.0%
2025-03-31$-0.25$-0.14+44.0%
2024-12-31$-0.17$-0.19-11.0%$250000.00-32.8%
2024-09-30$-0.20$-0.25-25.0%
2024-06-30$-0.23$-0.18+21.7%
2024-03-31$-0.25$-0.27-8.0%
2023-12-31$-0.34$-0.27+20.6%$372000.00
2023-09-30$-0.24$-0.22+8.3%

Frequently asked questions

Has Cognition Therapeutics Inc beaten earnings estimates?
Cognition Therapeutics Inc has beaten Wall Street EPS estimates in 6 of its last 8 quarterly reports, with an average EPS surprise of +53.5% over the last 4 quarters.
How does CGTX stock react to earnings?
CGTX stock has moved an average of -7.2% in the trading day following earnings over its last 3 reports, with positive reactions in 33% of those quarters.